Herpesvirus Infections and Risk of Parkinson's Disease.

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY
Neurodegenerative Diseases Pub Date : 2020-01-01 Epub Date: 2021-01-18 DOI:10.1159/000512874
Alejandra Camacho-Soto, Irene Faust, Brad A Racette, David B Clifford, Harvey Checkoway, Susan Searles Nielsen
{"title":"Herpesvirus Infections and Risk of Parkinson's Disease.","authors":"Alejandra Camacho-Soto,&nbsp;Irene Faust,&nbsp;Brad A Racette,&nbsp;David B Clifford,&nbsp;Harvey Checkoway,&nbsp;Susan Searles Nielsen","doi":"10.1159/000512874","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Herpesviruses might play a role in the pathogenesis of neurodegenerative disorders. We sought to examine a possible association between alpha herpesvirus infections and Parkinson's disease.</p><p><strong>Methods: </strong>We conducted a population-based case-control study of incident Parkinson's disease in 2009 Medicare beneficiaries age 66-90 years (89,790 cases, 118,095 randomly selected comparable controls). We classified beneficiaries with any diagnosis code for \"herpes simplex\" and/or \"herpes zoster\" in the previous 5 years as having had the respective alpha herpesviruses. In beneficiaries with Part D prescription coverage, we also identified those prescribed anti-herpetic medications. We calculated odds ratios (OR) and 95% CI between alpha herpesvirus diagnosis/treatment and Parkinson's disease with logistic regression, with adjustment for age, sex, race/ethnicity, smoking, and use of medical care.</p><p><strong>Results: </strong>Parkinson's disease risk was inversely associated with herpes simplex (OR 0.79, 95% CI 0.74-0.84), herpes zoster (OR 0.88, 95% CI 0.85-0.91), and anti-herpetic medications (OR 0.87, 95% CI 0.80-0.96).</p><p><strong>Conclusion: </strong>Herpesvirus infection or treatment might reduce risk of Parkinson's disease, but future studies will be required to explore whether this inverse association is causal.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":"20 2-3","pages":"97-103"},"PeriodicalIF":1.9000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000512874","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000512874","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 9

Abstract

Introduction: Herpesviruses might play a role in the pathogenesis of neurodegenerative disorders. We sought to examine a possible association between alpha herpesvirus infections and Parkinson's disease.

Methods: We conducted a population-based case-control study of incident Parkinson's disease in 2009 Medicare beneficiaries age 66-90 years (89,790 cases, 118,095 randomly selected comparable controls). We classified beneficiaries with any diagnosis code for "herpes simplex" and/or "herpes zoster" in the previous 5 years as having had the respective alpha herpesviruses. In beneficiaries with Part D prescription coverage, we also identified those prescribed anti-herpetic medications. We calculated odds ratios (OR) and 95% CI between alpha herpesvirus diagnosis/treatment and Parkinson's disease with logistic regression, with adjustment for age, sex, race/ethnicity, smoking, and use of medical care.

Results: Parkinson's disease risk was inversely associated with herpes simplex (OR 0.79, 95% CI 0.74-0.84), herpes zoster (OR 0.88, 95% CI 0.85-0.91), and anti-herpetic medications (OR 0.87, 95% CI 0.80-0.96).

Conclusion: Herpesvirus infection or treatment might reduce risk of Parkinson's disease, but future studies will be required to explore whether this inverse association is causal.

疱疹病毒感染与帕金森病的风险
引言:疱疹病毒可能在神经退行性疾病的发病机制中发挥作用。我们试图研究阿尔法疱疹病毒感染与帕金森病之间的可能联系。方法:我们对2009年年龄在66-90岁的医疗保险受益人(89790例,118095例随机选择的可比对照)的帕金森病事件进行了一项基于人群的病例对照研究。我们将过去5年中任何诊断代码为“单纯疱疹”和/或“带状疱疹”的受益人归类为患有各自的甲型疱疹病毒。在D部分处方覆盖的受益人中,我们还确定了那些处方的抗疱疹药物。我们通过逻辑回归计算了α疱疹病毒诊断/治疗与帕金森氏症之间的比值比(OR)和95%CI,并对年龄、性别、种族/民族、吸烟和医疗服务的使用进行了调整。结果:帕金森病风险与单纯疱疹(OR 0.79,95%CI 0.74-0.84)、带状疱疹(OR 0.88,95%CI 0.85-0.91)和抗疱疹药物(OR 0.87,95%CI 0.80-0.96)呈负相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurodegenerative Diseases
Neurodegenerative Diseases 医学-临床神经学
CiteScore
5.90
自引率
0.00%
发文量
14
审稿时长
6-12 weeks
期刊介绍: ''Neurodegenerative Diseases'' is a bimonthly, multidisciplinary journal for the publication of advances in the understanding of neurodegenerative diseases, including Alzheimer''s disease, Parkinson''s disease, amyotrophic lateral sclerosis, Huntington''s disease and related neurological and psychiatric disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信